Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Premiere Oncology of Arizona
Study ID
NCT00318513
Phase
PHASE1
Status
Unknown

Conditions

  • Lymphedema

Eligibility Criteria

Sex
FEMALE
Age
0 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to determine the safety and side effects of bevacizumab in subjects with lymphedema who will initially receive bevacizumab alone and then in combination with standard manual lymphatic drainage (MLD) and combined decongestive therapy (CDT). This study will help to determine the dose of bevacizumab to be used in future studies of subjects with lymphedema.

Key Dates

First listed
Apr 26, 2006
Status verified
Apr 2006

Study Design

Enrollment
35 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Premiere Oncology of ArizonaScottsdaleArizona85260
Michael S Gordon, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

By research site
Premiere Oncology of Arizona· Scottsdale, AZ

Related Studies